About: http://webisa.webdatacommons.org/375634070

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The company promoted Revlimid, which was approved in June 2006 for multiple myeloma, for brain cancer and cancers including lymphoma and leukemia.
http://www.w3.org/ns/prov#wasQuotedFrom	northjersey.com